UCL Division of Infection & Immunity
Research groups and centres in the Division form part of either the Research Department of Immunology or the Research Department of Infection.
Professor Deenan Pillay, Head of the Research Department of Infection:
mini lecture on the challenges of HIV (UCLtv).
Information about the Research Groups and Centres and their areas of research is given below.
These centres or research networks provide additional information about the breadth of research carried out in the Division.
- MRC/UCL Centre for Medical Molecular Virology
- UCL Immunology Consortium
- Innate Immunity
- Tumour Immunology, Cellular and Gene Therapy
- Research Department of Infection
- Immunology of Viral Hepatitis
- Centre for Clinical Microbiology
- Wohl Virion Research Centre
- Academic Centre for Travel Medicine
- Bloomsbury Institute of Pathogen Research (BiPR)
Bloomsbury Institute of Pathogen Research (BiPR)
BiPR was launched formally on 8 November, 2011. This new partnership between the London School of Hygiene & Tropical Medicine and University College London, will form a centre for leading research on infectious diseases combining basic science, translational and clinical expertise across our institutions, and associated hospitals, to provide an optimal environment to produce new drugs, vaccines and diagnostics.
A lesson in science communication?
Researchers from Professor Greg Towers’ and Paul Kellam’s groups, with colleagues from the Department of Zoology, University of Oxford, published an article in Retrovirology showing that the virus called XMRV that has been associated with chronic fatigue/ME and prostate cancer cannot be a human pathogen. It received a great deal of press interest.
As Professor Towers comments “the blogs that lead from a lot of these articles are very entertaining and illustrative of the pitfalls in science communication!”
Original Article: Stéphane Hué, Eleanor R Gray, Astrid Gall, Aris Katzourakis, Choon Ping Tan, Charlotte J Houldcroft, Stuart McLaren, Deenan Pillay, Andrew Futreal, Jeremy AGarson, Oliver G Pybus, Paul Kellam and Greg J Towers
Disease-associated XMRV sequences are consistent with laboratory contamination
Retrovirology 2010, 7:111doi:10.1186/1742-4690-7-111
Simulect is a chimerized mouse/human monoclonal antibody (anti-CD25) that is used to condition solid organ transplant patients to reduce the risk of acute rejection. The drug has been used to treat more than 150,000 transplant patients. The royalty income to UCL Business that has been generated from this product has just reached the £15 million mark. More..
Our researchers produce many exciting images of their work: we show some of them on these pages...
Dr Clare Jolly (Wohl)
3D tomographic model of cell-cell spread at the T cell virological synapse. Virus (red spheres) is being transmitted from an HIV-1 infected T cell (right, red plasma
membrane) to a target T cell (left, yellow plasma membrane).
Tomography and modelling was performed by Dr Sonja Welsch.
Page last modified on 26 mar 12 16:41 by Karen Rumsey